LEF1 and acute lymphoblastic leukemia: We found that B-ALL and T-ALL patients with high compared to low LEF1 expression showed no significant differences for overall survival (OS) (11.0 months vs 17.5 months, P = 0.294; 18 months vs 57 months, P = 0.408) (Fig 2A and 2C).